HQYNasdaqServices-Business Services, NECFiscal year ends January 31
HEALTHEQUITY, INC.
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Aug 27, 2026
$93.07+1.04 (+1.13%)
Close on Oct 19, 2026
- Market cap
- $7.82B
- P/E (TTM)
- 33.6
- Dividend yield
- –
Healthequity statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Services-Business Services, NEC companies for comparison
Valuation
| Measure | Healthequity | Industry median |
|---|---|---|
| Market Cap | $7.70B | $288.35M |
| Enterprise Value | $8.37B | $295.96M |
| PE Ratio | 33.60 | 25.62 |
| PS Ratio | 5.65 | 2.36 |
| PB Ratio | 3.87 | 2.67 |
| P/FCF Ratio | 15.78 | 15.03 |
| P/OCF Ratio | 15.71 | 13.00 |
Enterprise value
| Measure | Healthequity | Industry median |
|---|---|---|
| EV / Sales | 6.15 | 2.14 |
| EV / EBITDA | 16.45 | 16.16 |
| EV / EBIT | 23.83 | 20.79 |
| EV / FCF | 17.17 | 15.26 |
Income (trailing twelve months)
| Measure | Healthequity | Industry median |
|---|---|---|
| Revenue | $1.36B | $285.88M |
| Gross Profit | $970.48M | $158.88M |
| Operating Income | $351.41M | -$627.44K |
| Pretax Income | $308.71M | -$295.11K |
| Net Income | $236.49M | -$298.85K |
| EBITDA | $509.04M | -$186.20K |
| EPS (Diluted) | $2.77 | $0.00 |
Margins
| Measure | Healthequity | Industry median |
|---|---|---|
| Gross Margin | 71.2% | 55.8% |
| Operating Margin | 25.8% | -1.97% |
| Pretax Margin | 22.7% | -0.50% |
| Profit Margin | 17.4% | -1.84% |
| EBITDA Margin | 37.4% | 0.49% |
| FCF Margin | 35.8% | 10.0% |
Returns
| Measure | Healthequity | Industry median |
|---|---|---|
| Return on Equity (ROE) | 11.4% | 1.05% |
| Return on Assets (ROA) | 7.07% | -3.10% |
| Return on Invested Capital (ROIC) | 9.76% | -0.51% |
| Return on Capital Employed (ROCE) | 11.3% | -0.46% |
Growth
| Measure | Healthequity | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7.34% | 9.79% |
| Net Income Growth (YoY) | 62.2% | 7.20% |
| EPS Growth (YoY) | 67.9% | 10.4% |
| FCF Growth (YoY) | 33.5% | 17.8% |
| Revenue Growth (3Y CAGR) | 15.1% | 7.56% |
| Revenue Growth (5Y CAGR) | 12.4% | 12.3% |
| EPS Growth (5Y CAGR) | 83.0% | 12.4% |
Balance sheet
| Measure | Healthequity | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $256.00M | $43.10M |
| Total Debt | $931.06M | $204.00M |
| Net Cash (Debt) | -$675.06M | $1.87M |
| Net Cash Per Share | -$8.16 | $0.14 |
| Equity (Book Value) | $1.99B | $52.02M |
| Book Value Per Share | $24.06 | $1.91 |
| Tangible Book Value | -$705.83M | $3.03M |
| Working Capital | $306.43M | $14.05M |
Financial position
| Measure | Healthequity | Industry median |
|---|---|---|
| Current Ratio | 2.99 | 1.39 |
| Quick Ratio | 2.46 | 0.93 |
| Debt / Equity | 0.47 | 0.55 |
| Debt / EBITDA | 1.83 | 2.80 |
| Debt / FCF | 1.91 | 2.97 |
| Net Debt / EBITDA | 1.33 | 1.50 |
| Interest Coverage | 6.69 | -0.66 |
Cash flow (trailing twelve months)
| Measure | Healthequity | Industry median |
|---|---|---|
| Operating Cash Flow | $490.18M | $8.52M |
| Capital Expenditures | -$2.45M | -$5.59M |
| Free Cash Flow | $487.73M | $47.39M |
| FCF Per Share | $5.90 | $0.69 |
Efficiency
| Measure | Healthequity | Industry median |
|---|---|---|
| Asset Turnover | 0.41 | 0.63 |
| Revenue Per Employee | $484.05K | $393.50K |
| Profits Per Employee | $84.04K | -$4.74K |
| Employee Count | 2,814 | 530 |
Dividends and yields
| Measure | Healthequity | Industry median |
|---|---|---|
| Earnings Yield | 3.07% | -0.95% |
| FCF Yield | 6.34% | 4.01% |
| Buyback Yield | 5.25% | 3.24% |
| Shareholder Yield | 5.25% | 3.43% |
Shares
| Measure | Healthequity | Industry median |
|---|---|---|
| Shares Outstanding | 82,715,300 | 59,289,300 |
| Shares Change (YoY) | -3.26% | 2.27% |
| Shares Change (QoQ) | -1.21% | 0.06% |
| Float | 81,308,900 | 52,876,900 |
| Shares Held by Insiders | 1.70% | 13.2% |
| Shares Held by Institutions | 108.5% | 66.9% |
Taxes
| Measure | Healthequity | Industry median |
|---|---|---|
| Income Tax | $72.22M | $1.64M |
| Effective Tax Rate | 23.4% | 22.0% |
Scores
| Measure | Healthequity | Industry median |
|---|---|---|
| Graham Number | $38.72 | $15.50 |
| Graham Upside | -58.4% | -55.8% |
| Altman Z-Score | 4.56 | 1.50 |
| Piotroski F-Score | 9 | 5 |
| Beneish M-Score | -2.77 | -2.81 |
Calculated by StockData from Healthequity's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.